台股 » 個股 » 台微體 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台微體

(4152)
  • 股價
    99.6
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    120
  • 產業
    上櫃 永豐餘
  • 60人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
台微體 (4152)籌碼相關-兆豐-中壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-中壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2021/05/2800.00177.5077.20-1383-0.26%
2021/05/18168.5000.0068.6013440.29%
2021/04/1500.00087.9088.800409-0.01%
2021/03/1600.00187.6085.10-1357-0.28%
2021/03/15183.6000.0089.6013470.29%
2021/02/0100.00183.7083.70-1274-0.36%
2021/01/25172.7000.0072.7012230.45%
2021/01/2100.00172.0071.00-1205-0.49%
2021/01/2000.00268.8068.70-2195-1.02%
2020/12/29267.3000.0064.5024300.46%
2020/10/1900.00166.4066.40-1622-0.16%
2020/10/16168.4000.0067.1016270.16%
2020/09/1800.00167.2067.50-1807-0.12%
2020/07/2700.00180.7078.30-1804-0.12%
2020/07/2300.00187.2087.20-1781-0.13%
2020/07/22190.8000.0089.5017730.13%
2020/07/17199.50195.6095.6007260.00%
2020/07/101107.5000.00100.5015690.18%
2020/07/081103.0000.00102.5014720.21%
2020/07/06192.0000.0093.8014110.24%
2020/03/1900.00555.4055.40-541-12.04%
2020/03/1800.00961.7161.50-940-22.14%
2020/03/1600.00861.1361.40-844-18.06%
2019/12/1000.00184.4084.50-1139-0.72%
2019/11/06177.8000.0077.901941.06%
2019/11/05178.5000.0078.001921.08%
2019/11/01179.0000.0079.501901.11%
2019/10/31179.1000.0079.501901.11%
2019/10/29179.5000.0079.001911.09%
2019/10/23082.7000.0082.700900.01%
2019/06/26180.4000.0081.001372.70%
2019/05/24381.3300.0081.3032910.22%
2019/05/21182.8000.0084.001293.35%
2019/03/22192.4000.0092.301293.41%
2019/03/15194.2000.0094.201283.49%
2019/01/08699.5000.0099.5063019.72%
2019/01/07290.1000.0090.502296.88%
2018/12/14197.5000.0098.801303.32%
2018/12/13198.5000.0098.501303.31%
2018/10/0500.00199.50101.00-140-2.49%
2018/07/131114.5000.00113.001701.41%
2018/05/3000.00198.8096.70-1117-0.85%
2018/05/2300.00198.5098.50-1132-0.76%
2018/05/2200.00198.2098.00-1135-0.74%
2018/05/1700.001100.5099.00-1143-0.70%
2018/04/021115.5000.00114.0011330.75%
2018/03/303111.5000.00109.0031312.28%
生技最大金額合作案 台微體關節止痛針劑簽200億元授權Anue鉅亨-2022/06/13
台微體 相關文章
台微體 相關影音